The Global Alzheimer’s Therapeutics Market Growth is Driven by the Rising Prevalence of Alzheimer’s Disease and the Expanding Adoption of Disease Modifying Therapies.Austin, Dec. 01, 2025 (GLOBE ...
TSRA-196 is a potential one-time treatment to precisely correct the genetic mutation underlying AATD, with Investigational New Drug filing expected by the end of the year Tessera to receive $150 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback